ClinicalTrials.Veeva

Menu
A

Azienda Sanitaria Universitaria Friuli Centrale | Rheumatology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Encorafenib
Binimetinib
5-Fluorouracil
THR-149
Solu-Medrol
Trifluridine
Doxorubicin
Methylprednisolone
Dostarlimab
Trastuzumab

Parent organization

This site is a part of Azienda Sanitaria Universitaria Friuli Centrale

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 18 total trials

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the...

Active, not recruiting
Melanoma
Drug: Binimetinib
Drug: Encorafenib

This study is researching an experimental drug called odronextamab, referred to as study drug, when used in combination with chemotherapy. The study...

Enrolling
Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Doxorubicin
Drug: Prednisone/Prednisolone

The purpose of the Columbus-AD study is to evaluate the efficacy and safety of 12 months of encorafenib in combination with binimetinib in adjuvant s...

Active, not recruiting
Melanoma
Drug: Placebo to match Encorafenib ; Placebo to match Binimetinib
Drug: Encorafenib and Binimetinib

Phase 3, randomized, multicentre study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficien...

Enrolling
Endometrial Cancer
Drug: Carboplatin-Paclitaxel
Drug: Dostarlimab

The aims of this study are to evaluate if an intensified adjuvant treatment with FOLFOXIRI could increase the rate of cases with undetectable ct-DNA...

Enrolling
RAS Wild-type Colon Cancer
Stage II Colon Cancer
Drug: 5-Fluorouracil continuous infusion FOLFOXIRI schedule
Drug: L-Leucovorin

Trial sponsors

I
U
Angelini Pharma logo
A
C
Ipsen logo
Oxurion logo
Pfizer logo
Pierre Fabre logo
Regeneron Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems